Member Info for metis20

Koh Tat Seng, the current MAYA CFO, was CFO of PURE when they listed on AIM in 2007, he moved from PURE in 2008 presumably to MAYA. PURE moved to the main market in October 2016. An example of an AIM listed Chinese company which has survived! http://investors.mayairgroup.com/directors/

On the MAYA website, the major shareholders list was apparently last updated on 7th July 2015... http://investors.mayairgroup.com/securities-information/

trade 13:41 on Friday 19th at 81p when the bid was around 79p. Just reported. Interesting to see if that is part of the buy back.

going well - from today's half-year results - While the result of the EU Referendum has created increased economic uncertainty, customer interest since then has been robust with visitor numbers to our sites around 20% ahead year on year. Our private sale reservation rate since 1 July is currently 17% ahead of the same period last year. The Group is now trading through the traditionally slower summer weeks but customer demand remains encouraging and we anticipate a good autumn sales season

from IPO 7th May 2015 which was at 130p http://www.investegate.co.uk/mayair-group-plc--maya-/rns/admission-to-aim-and-first-day-of-dealings/201505070700224260M/ http://www.mayairgroup.com/ share buy back in progress - presumably to bolster sp. From 5th June 2016 AGM statement In recent years, the Group has diversified its product offering to include indoor clean air solutions for the commercial and residential markets. Key flagship commercial projects so far include Shanghai airport terminals, Shanghai International Convention Centre, SOHO Galaxy office development in Beijing and Chengdu's Subway. MayAir is well positioned to take advantage of the growing demand for air purification technology and in the year to 31 December 2015, the Group reported record figures with revenue rising by 45% to US$63.6 million and underlying operating profit rising by 19% to US$7.7 million. MayAir Group listed on AIM in May 2015 with the ticker MAYA.L.

From today's RNS "Completion is scheduled to take place on or before 30 September 2016 or such later date as the parties may agree. On completion the existing directors will resign and be replaced by directors nominated by the investors."

http://www.tristel.com/sites/default/files/a47_-_optimising_cleaning_and_disinfection_processes_csj_aug._2016.pdf Cover story Optimising cleaning and disinfection processes This Tristel story is available - scroll down - without registering...

are not going to crash! http://www.cityam.com/246712/brexit-doom-mongers-wrong-london-house-prices-arent-going

"Our updated valuation of Angle is $171m (vs $136m previously)." Edison issues ADR update on Angle (ANPCY) Recent newsflow from Angle and the FY16 report released last week showed progress in developing and commercializing the liquid biopsy diagnostic system Parsortix. The R&D strategy is progressing, with the ovarian cancer trials recruiting first patients in the US and Europe and on track to deliver data around end-2016, while the first research use sales met our expectations and a new large client is on board. Our updated valuation of Angle is $171m (vs $136m previously). We have revised our valuation of Angle and now include metastatic breast cancer and prostate cancer applications in addition to our previous DCF-based valuation of Angle's core operations and ovarian cancer application. We calculate the two new applications add $20m to Angle's valuation. Following strong news flow in recent months, ramp-up of R&D activities and initial sales meeting our expectations, we increase our valuation to $171m (from $136m) or $23/ADR.

Trading update and special dividend For the year ended 30 June 2016 Tristel will record turnover in excess of £17 million (2015: £15.3 million) and pre-tax profit (before share-based payments and unrealised currency gains) of at least £3.1 million (2015: £2.6 million). Both turnover and pre-tax profit are ahead of market expectations. http://www.investegate.co.uk/tristel-plc--tstl-/rns/trading-update--special-dividend---acquisition/201607210700077820E/

Looking forward to a strong trading update on Thursday. Also an Open Day http://www.investegate.co.uk/tristel-plc--tstl-/rns/shareholder-open-day---notice-of-trading-update/201605250700131737Z/ (Ticket)availability is limited so please contact the Company via tristel@walbrook.com or call 01638 721 500 and press 1 for customer services to reserve an entry ticket. From the half-yearly report back in February "We are pleased to report strong half-on-half profits growth, which has translated into an increase in cash and a substantial increase in the interim dividend. Overseas sales accounted for 36% of total revenue and increased by 20% during the period. Our international expansion continues with many regulatory approvals awaited, not only in healthcare markets in which we already sell, but also in countries in which we have no presence. This includes the United States. "Two products have been selected for our approach to the US market, and we are in dialogue with the FDA in preparation for a full regulatory approval submission during 2016." sp recovering well from that Brexit inspired panic!

Why the second tick up early yesterday? It shot up from US$0.26/0.27 to 0.27/0.32 - see via trades tab above. No sign of a delayed trade yet, but that could still appear. Otherwise presumably there is a large a quite pricy buy order in.

to things livening up here soon. From 20th May post when the sp was 0.265 - "$9.5m in CASH in the bank, 2 more plots worth at least $12m. About to be sold anytime, a potential special divi payback + a 10% stake that is worth another few $m. And yet the mcap is $7m!!!"

July 2015 IPO The Offer comprises the sale by the Selling Shareholders of 37,691,763 Ordinary Shares at the Offer Price of 139 pence per Offer Share. Many of those in at the IPO have presumably sold it down from almost 300p!

Commenting on the results, Mark Watkin Jones, Chief Executive Officer of Watkin Jones plc, said: "Following on from our successful admission to AIM in March this year, we are delighted to report such a strong maiden set of half year results today. http://www.investegate.co.uk/watkin-jones-plc--wjg-/rns/half-year-results/201606090700076766A/

Tipped in SCSW this month when at 232.5p. Very good momentum. Way oversold. RSI about 22 currently. divi about 3.5%. Strong AGM statement. http://www.investegate.co.uk/safecharge-int-grp--sch-/rns/agm-statement/201605180700075192Y/

Delayed trade 14:42 today - 50k @ 115p moved the sp up encouragingly. Total of £57.5k.

the sudden interest? Larger volume yesterday than the total for the last six months!

Another 50k delayed buy today at 15:26 hrs sp $0.28 - same price and trade size as Friday - mopped up almost all the sells. Someone is accumulating. Maybe Mr Lillingstone continues to buy - http://www.investegate.co.uk/tejoori-limited--tji-/rns/holding-s--in-company/201605171035034704Y/

I wondered why the sells today did not produce a sp fall - it is because the relatively large buy orders are still there - today's delayed trade was for 50k at 28p at 16:18 hrs. That single trade mopped up all the sells from the past 3 days.